Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Research, development and commercialization of its novel cell therapies178.03M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United Kingdom (U.K.)176.8M99.31%
United States (U.S.)1.24M0.69%